参考文献/References:
[1] Kroman SL,Roos EM,Bennell KL,et al.Measurement properties of performance-based outcome measures to assess physical function in young and middle-aged people known to be at high risk of hip and/or knee osteoarthritis:a systematic review[J].Osteoarthritis Cartilage,2014,22(1):26-39.
[2] Corbett MS,Rice SJC,Madurasinghe V,et al.Acupuncture and other physical treatments for the relief of pain due to osteoarthritis of the knee:network meta-analysis[J].Centre for Reviews and Dissemination(UK),2013,21(9):1290-1298.
[3] 张宇,赵永见,周泉,等.IL-1β诱导小鼠椎间盘软骨终板细胞炎性退变的细胞模型研究[J].免疫学杂志,2012,28(8):665-668.
[4] Zhang Y,Ross AC.Retinoic Acid and the transcription factor mafB act together[J].J Cell Biochem,2013,114(2):471-479.
[5] Suri S,Gill SE,Massena de Camin S,et al.Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis[J].Ann Rheum Dis,2007,66(11):1423-1428.
[6] Aigner T,Sachse A,Gebhard PM,et al.Osteoarthritis:pathobiology-targets and ways for therapeutic intervention[J].Adv Drug Deliv Rev,2006,58(2):128-149.
[7] Goldring MB.Update on the biology of the chondrocyte and new approaches to treating cartilage diseases[J].Best Pract Res Clin Rheumatol,2006,20(5):1003-1025.
[8] Troeberg L,Nagase H.Proteases involved in cartilage matrix degradation in osteoarthritis[J].Biochim Biophys Acta,2012,1824(1):133-145.
[9] Lin EA,Liu CJ.The role of ADAMTS in arthritis [J].Protein,2010,1(1):33-47.
[10] Wu CW,Tchetina EV,Mwale F,et al.Proteolysis involving matrix metalloproteinase 13(collagenase-3)is required for chondrocyte differentiation that is associated with matrix mineralization[J].J Bone Miner Res,2002,17(4):639-651.
[11] Dahlberg L,Billinghurst RC,Manner P,et al.Selective enhancement of collagenase-mediated cleavage of resident type Ⅱ collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1(matrix metalloproteinase 1)[J].Arthritis Rheum,2000,43(3):673-682.
[12] Aigner T,Dudhia J.Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis:a hypothesis[J].Ann Rheum Dis,1997,56(5):287-291.
[13] Sekiya I,Tsuji K,Koopman P,et al.SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line,TC6[J].J Biol Chem,2000,275(15):10738-10744.
[14] Ushijima T,Okazaki K,Tsushima H,et al.CCAAT/enhancer-binding protein β regulates the repression of type Ⅱ collagen expression during the differentiation from proliferative to hypertrophic chondrocytes[J].J Biol Chem,2014,289(5):2852-2863.
[15] Okubo Y,Reddi AH.Thyroxine downregulates Sox9 and promotes chondrocyte hypertrophy [J].Biochem Biophys Res Commun,2003,306(1):186-190.
[16] Song Y,Xu K,Yu C,et al.The use of mechano growth factor to prevent cartilage degeneration in knee osteoarthritis[J].J Tissue Eng Regen Med,2018,12(3):738-749.
[17] 李保驰,王维山,董金波,等.MMP-3、MMP-13在骨性关节炎患者滑膜中的表达及意义[J].中国骨质疏松杂志,2014,20(6):593-596.